Cite
HARVARD Citation
Kumthekar, P. et al. (2023). A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics. Neuro-oncology. 25 (3), pp. 557-565. [Online].